These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18240803)

  • 1. HIV services threatened by cutbacks and drug costs.
    Tighe A
    Nurs Stand; 2008 Jan 9-15; 22(18):33. PubMed ID: 18240803
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost imposes barrier to HIV treatment in Missouri.
    AIDS Policy Law; 2005 Jul; 20(13):2. PubMed ID: 16044518
    [No Abstract]   [Full Text] [Related]  

  • 3. The new Medicare drug plan: implications for people living with HIV/AIDS.
    HRSA Careaction; 2005 Oct; ():1-8. PubMed ID: 16479678
    [No Abstract]   [Full Text] [Related]  

  • 4. The changing outlook for worldwide HIV treatment.
    Gonsalves G
    GMHC Treat Issues; 2001 Apr; 15(4):3-5. PubMed ID: 11590941
    [No Abstract]   [Full Text] [Related]  

  • 5. The looming crisis in drug pricing.
    Delaney M
    GMHC Treat Issues; 2002 Apr; 16(4):12. PubMed ID: 12141258
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost of access to HIV treatment.
    Galatowitsch P; Siegfried N
    Science; 2006 Dec; 314(5805):1540-1; author reply 1540-1. PubMed ID: 17158305
    [No Abstract]   [Full Text] [Related]  

  • 7. Progress at last? South Africa relents on HIV drugs.
    Huff B
    GMHC Treat Issues; 2003; 17(7-8):16, 15. PubMed ID: 14686317
    [No Abstract]   [Full Text] [Related]  

  • 8. Bringing dawn to night.
    Zuniga JM
    IAPAC Mon; 2004 Feb; 10(2):48, 52. PubMed ID: 15106523
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustaining treatment costs: who will pay?
    Zewdie D; De Cock K; Piot P
    AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744
    [No Abstract]   [Full Text] [Related]  

  • 10. Khousalya Periaswamy. Interview by Bob Huff.
    Periaswamy K
    GMHC Treat Issues; 2004; 18(5-6):3-5. PubMed ID: 15359436
    [No Abstract]   [Full Text] [Related]  

  • 11. Haiti--a battle against poverty and HIV.
    Winfield C
    Posit Aware; 2003; 14(2):30. PubMed ID: 12693371
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glaxo Wellcome, Germany, spends 60.000 DM for African HIV projects in Uganda and Malawi].
    Krankenpfl J; 1999 Dec; 37(12):479. PubMed ID: 10734858
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

  • 14. CalPERS to reopen drug giant's AIDS drug-pricing issue.
    AIDS Policy Law; 2003 Dec; 18(22):9. PubMed ID: 14974405
    [No Abstract]   [Full Text] [Related]  

  • 15. Africa finds drug giants guilty of excessive pricing.
    AIDS Policy Law; 2003 Dec; 18(22):5. PubMed ID: 14974397
    [No Abstract]   [Full Text] [Related]  

  • 16. ADAP spending, patient base grow but budget shortfalls persist.
    AIDS Policy Law; 2001 Apr; 16(8):8-9. PubMed ID: 11590862
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug prices.
    Vázquez E
    Posit Aware; 2003; 14(1):61-2. PubMed ID: 12630376
    [No Abstract]   [Full Text] [Related]  

  • 18. 3 by 5 initiative: treating 3 million by 2005.
    East Mediterr Health J; 2002 Nov; 8(6):835-7. PubMed ID: 15568463
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug pricing.
    AIDS Treat News; 2001 Jan; (377):6. PubMed ID: 11862811
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV treatment strategies.
    Slotten R
    Posit Aware; 2012; 24(5):19-22. PubMed ID: 23091879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.